Letter: disentangling the role of redox-active compounds in the development of inflammatory bowel diseases-moving towards causal associations. Authors' reply

Aliment Pharmacol Ther. 2023 May;57(9):1048-1049. doi: 10.1111/apt.17468.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Humans
  • Inflammatory Bowel Diseases* / drug therapy